200 Tablet, Manufactured By Cipla Ltd, TReatment Anti Cancer, Form Tablet

Pazinib 200 tablet contains pazopanib that is classified under the category of medications known as protein kinase inhibitors. It is employed in medical care of kidney cancer that includes advanced or extend to additional organs and soft tissue sarcoma. Soft tissue sarcoma is a variety of cancer that affects the supportive tissues concerning the anatomy it can occur in the muscles, Fat tissues or other, Blood vessels tissues surround and, That support protect the organs. Your healthcare provider may ask you to undergo certain diagnostic assessments to evaluate the performance of your liver, Kidney and heart and may monitor the force of your blood prior to and while you take pazinib 200 tablet. Before taking gbnkewyord, Consult with consult your physician if you experience any heart, Kidney or had lung, Liver diseases problems, Thyroid problems, Bleeding or blood clotting issues, Stomach or bowel problems perforation or fistula, Aneurysm enlargement and weakening of a blood vessel wall or have high blood pressure. Pazinib 200 tablet is not advisable in Women in pregnancy and lactation women. Pazinib 200 tablet is not recommended in children and adolescents below 18 years of age. Consult with your doctor before taking pazinib 200 tablet. The typical option side effects of pazinib 200 tablet are indigestion, Bloating, Flatulence, Nosebleed, Dry mouth, Mouth ulcers or dizziness. Consult with reach out to your healthcare provider if the symptoms do not improve or get worse. Uses of pazinib 200 tablet treats kidney cancer sarcoma a cancer that begins in bones or inside any soft layers of the body